| Molecular Diagnostics in Cancer Testing | | | | market segments and the dollar volume of sales, |
| Molecular diagnostics is a rapidly-advancing area of | | | | both in the United States and worldwide. |
| research and medicine, with new technologies and | | | | Key Chapters of the report : |
| applications being continually added. The | | | | 1. Overview 6 |
| technologies that come under the umbrella of | | | | 1.1 Statement of Report 6 |
| molecular diagnostics include first-generation | | | | 1.2 About This Report 6 |
| amplification, DNA probes, fluorescent in-situ | | | | 1.3 Scope of the Report 7 |
| hybridization (FISH), second-generation biochips | | | | 1.4 Objectives 7 |
| and microfluidics, next-generation signal detection, | | | | 1.5 Methodology 8 |
| biosensors and molecular labels, and gene | | | | 1.6 Executive Summary 9 |
| expression profiling using microarrays. ( ) | | | | 2. Introduction to Molecular Diagnostics 13 |
| These technologies are improving the discovery | | | | 2.1 Opening Up of Opportunities in Molecular |
| of therapeutic molecules for cancer, the | | | | Diagnostics 13 |
| screening, diagnosis and classification of cancer | | | | 2.2 Impact of the Human Genome Project on |
| patients, and the optimization of drug therapy. | | | | Molecular Diagnostics 15 |
| This report describes the specific segment of the | | | | 2.3 Considerations for Molecular and Clinical |
| in vitro diagnostics (IVD) market known as | | | | Diagnostics 16 |
| molecular diagnostics (MD), with a specialization in | | | | 2.4 Molecular Diagnostics in the Post-Genomic Era |
| the MD tests for cancer. In the current medical | | | | 19 |
| diagnostics market, molecular diagnostics for | | | | 2.5 Advances in Molecular Diagnostics Technologies |
| cancer testing offers one of the brightest areas | | | | 20 |
| for growth and innovation. The confluence of | | | | 2.6 Oligonucleotide Array Platforms 21 |
| breakthroughs in genomics, proteomics, and the | | | | 2.7 Emerging Cancer Personalized Medicine Market |
| development of microarray devices to measure | | | | 22 |
| analytes in the blood and various body tissues, | | | | 2.8 Companion Tests for Drug Development 24 |
| has led to this revolutionary market segment | | | | 3. Cancer Diagnostics Molecular Testing Market 27 |
| offering the power of advanced analytical | | | | 3.1 Market Description 30 |
| techniques to the diagnosis and treatment of | | | | 3.1.1 Market Overview 30 |
| cancer. This report analyzes the size and growth | | | | 3.1.2 Tumor Markers 31 |
| of the molecular diagnostics market in its | | | | 3.1.3 Molecular Diagnostic Markers 39 |
| applications for cancer detection and therapy, | | | | 3.1. |
| examining the factors that influence the various | | | | |